E

EdiGene Inc.

50 employees

EdiGene is a biotechnology company that develops genome editing technologies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Genetic Diseases
Gene Therapy
Gene editing
Genetics
Genome editing
Cell Therapy
Cancer

Date founded

2015

Funding rounds raised

Total raised

$67M

from 28 investors over 28 rounds

E

EdiGene Inc. raised $62M on April 21, 2021

Investors: 夏尔巴股权投资管理有限公司, 雅惠投资, Sequoia Capital China, Lilly Asia Ventures, IDG Capital Partners, Loyal Valley Capital, 华盖资本有限责任公司, Kunlun Capital Pte. Ltd. and 博远资本

E

EdiGene Inc. raised $67M on October 13, 2020

Investors: Beijing Kunlun Tech Co Ltd (SZ:300418), 华盖资本有限责任公司, GREEN PINE CAPITAL PARTNERS, IDG Capital Partners, 雅惠投资, Sequoia Capital China and Lilly Asia Ventures

E

EdiGene Inc. raised $11M on September 17, 2019

Investors: Lilly Asia Ventures and IDG Capital Partners

E

EdiGene Inc. raised $10M on February 6, 2019

Investors: Lilly Asia Ventures, IDG Capital Partners and GREEN PINE CAPITAL PARTNERS

E

EdiGene Inc. raised $15M on August 13, 2018

Investors: IDG Capital Partners, 华盖资本有限责任公司, WI Harper Group and Lilly Asia Ventures

E

EdiGene Inc. raised $15M on December 19, 2017

Investors: FUJIFILM Corporation

E

EdiGene Inc. raised undisclosed on October 1, 2016

Investors: WI Harper Group and IDG Capital Partners

FAQ